Terms: = Breast cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Prognosis
140 results:
1. Exosomal miR-361-3p promotes the viability of breast cancer cells by targeting ETV7 and BATF2 to upregulate the pai-1/ERK pathway.
Li Y; Fan L; Yan A; Ren X; Zhao Y; Hua B
J Transl Med; 2024 Jan; 22(1):112. PubMed ID: 38282047
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a cancer-associated fibroblast classifier for predicting prognosis and therapeutic response in lung squamous cell carcinoma.
Lai X; Fu G; Du H; Xie Z; Lin S; Li Q; Lin K
Medicine (Baltimore); 2023 Sep; 102(38):e35005. PubMed ID: 37746966
[TBL] [Abstract] [Full Text] [Related]
3. Establishment and Analysis of an Individualized EMT-Related Gene Signature for the prognosis of breast cancer in Female Patients.
Xue W; Sun C; Yuan H; Yang X; Zhang Q; Liao Y; Guo H
Dis Markers; 2022; 2022():1289445. PubMed ID: 35937944
[TBL] [Abstract] [Full Text] [Related]
4.
Boissière-Michot F; Mollevi C; Baecker V; Crapez E; Jacot W
Int J Mol Med; 2022 Jun; 49(6):. PubMed ID: 35475537
[TBL] [Abstract] [Full Text] [Related]
5. Identification of AHSA1 as a Potential Therapeutic Target for breast cancer: Bioinformatics Analysis and in vitro Studies.
Shi W; Qi L; You XB; Chen YC; Xu YL; Yu WB; Huang MY; Zhao H; Lu JJ
Curr Cancer Drug Targets; 2022; 22(2):142-152. PubMed ID: 35034596
[TBL] [Abstract] [Full Text] [Related]
6. Human epidermal growth factor receptor 2 inhibits activating transcription factor 7 to promote breast cancer cell migration by activating histone lysine demethylase 1.
Lin J; Mao H; Ji Z; Lin W; Wang T
J Cancer Res Ther; 2021 Nov; 17(5):1192-1201. PubMed ID: 34850767
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic difficulties of men with breast cancer.
Fentiman IS
Breast J; 2021 Dec; 27(12):877-882. PubMed ID: 34652050
[TBL] [Abstract] [Full Text] [Related]
8. [uPA/pai-1 and EPClin®: Comparison of their impact on the management of intermediate-prognosis breast cancers].
Maniez P; Osada M; Reix N; Mathelin C
Gynecol Obstet Fertil Senol; 2022 Apr; 50(4):298-306. PubMed ID: 34626849
[TBL] [Abstract] [Full Text] [Related]
9. CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for pai-1.
Durlanik S; Fundel-Clemens K; Viollet C; Huber HJ; Lenter M; Kitt K; Pflanz S
Sci Rep; 2021 Jul; 11(1):14849. PubMed ID: 34290311
[TBL] [Abstract] [Full Text] [Related]
10. Serum Long Non-Coding RNAs PVT1, HOTAIR, and NEAT1 as Potential Biomarkers in Egyptian Women with breast cancer.
El-Fattah AAA; Sadik NAH; Shaker OG; Mohamed Kamal A; Shahin NN
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670447
[TBL] [Abstract] [Full Text] [Related]
11. The miR-1185-2-3p-GOLPH3L pathway promotes glucose metabolism in breast cancer by stabilizing p53-induced serpine1.
Xu Y; Chen W; Liang J; Zeng X; Ji K; Zhou J; Liao S; Wu J; Xing K; He Z; Yang Y; Liu Q; Zhu P; Liu Y; Li L; Liu M; Chen W; Huang W
J Exp Clin Cancer Res; 2021 Jan; 40(1):47. PubMed ID: 33509226
[TBL] [Abstract] [Full Text] [Related]
12. Knockdown of serpine1 reverses resistance of triple‑negative breast cancer to paclitaxel via suppression of VEGFA.
Zhang Q; Lei L; Jing D
Oncol Rep; 2020 Nov; 44(5):1875-1884. PubMed ID: 33000256
[TBL] [Abstract] [Full Text] [Related]
13. Effects of Weight Loss and Weight Regain on Circulating Biomarkers in Overweight/Obese breast cancer Survivors Enrolled in a Weight Loss Trial in the Rural Midwest.
Befort CA; Kimler BF; Bantis LE; Phillips TA; Fabian CJ
Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1321-1328. PubMed ID: 32277008
[TBL] [Abstract] [Full Text] [Related]
14. NAMPT, GRN, and serpine1 signature as predictor of disease progression and survival in gliomas.
Vachher M; Arora K; Burman A; Kumar B
J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
[TBL] [Abstract] [Full Text] [Related]
15. Impact of uPA/pai-1 and disseminated cytokeratin-positive cells in breast cancer.
Märkl B; Kazik M; Harbeck N; Jakubowicz E; Hoffmann R; Jung T; Steinfeld D; Schenkirsch G; Schlimok G; Oruzio D
BMC Cancer; 2019 Jul; 19(1):692. PubMed ID: 31307406
[TBL] [Abstract] [Full Text] [Related]
16. Stromal coexpression of uPA/pai-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
Singer CF; Filipits M; Jahn SW; Abete L; Jakesz R; Greil R; Bauernhofer T; Kwasny W; Seifert M; Fitzal F; Kastner M; Schmitt M; Moinfar F; Gnant M
Breast; 2019 Aug; 46():101-107. PubMed ID: 31132475
[TBL] [Abstract] [Full Text] [Related]
17. EndoPredict versus uPA/pai-1 in breast cancer: Comparison of markers and association with clinicopathological parameters.
Jakubowicz E; Martin B; Hoffmann R; Kröncke T; Jung T; Steierl R; Steinfeld D; Schenkirsch G; Kriegsmann J; Märkl B
Breast J; 2019 May; 25(3):450-454. PubMed ID: 31001905
[TBL] [Abstract] [Full Text] [Related]
18. Plasminogen Activator Inhibitor 1 (pai1) Promotes Actin Cytoskeleton Reorganization and Glycolytic Metabolism in Triple-Negative breast cancer.
Humphries BA; Buschhaus JM; Chen YC; Haley HR; Qyli T; Chiang B; Shen N; Rajendran S; Cutter A; Cheng YH; Chen YT; Cong J; Spinosa PC; Yoon E; Luker KE; Luker GD
Mol Cancer Res; 2019 May; 17(5):1142-1154. PubMed ID: 30718260
[TBL] [Abstract] [Full Text] [Related]
19. Correlation of Serum Levels of Urokinase Activation Plasminogen (uPA) and Its Inhibitor (pai-1) with Hormonal and HER-2 Status in the Early Invasive breast cancer.
Pusina S
Med Arch; 2018 Nov; 72(5):335-340. PubMed ID: 30524164
[TBL] [Abstract] [Full Text] [Related]
20. Epithelial-mesenchymal transition induced pai-1 is associated with prognosis of triple-negative breast cancer patients.
Xu J; Zhang W; Tang L; Chen W; Guan X
Gene; 2018 Sep; 670():7-14. PubMed ID: 29802992
[TBL] [Abstract] [Full Text] [Related]
[Next]
